These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

65 related items for PubMed ID: 6415264

  • 21. General pharmacological properties of the new angiotensin II receptor antagonist (+/-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl) biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate. Part I: Effects on central nervous system and other properties.
    Kito G, Morimoto S, Shiomi M.
    Arzneimittelforschung; 1996 Jun; 46(6):572-9. PubMed ID: 8767346
    [Abstract] [Full Text] [Related]

  • 22. Cephem antibiotics and alcohol metabolism.
    Yanagihara M, Okada K, Nozaki M, Tsurumi K, Fujimura H.
    Jpn J Antibiot; 1985 Mar; 38(3):634-42. PubMed ID: 3861880
    [Abstract] [Full Text] [Related]

  • 23. [Pharmacological studies on a new penicillin group antibiotic, sodium 6-[D(-)-alpha-(4-ethyl-2, 3-dioxo-1-piperazinecarboxamido)-alpha-phenylacetamido] penicillanate (T-1220). I. Effect on central and peripheral nervous systems (author's transl)].
    Takai A, Hirai S, Watanabe I, Hiraiwa T, Abe N.
    Jpn J Antibiot; 1977 Aug; 30(8):529-42. PubMed ID: 909142
    [No Abstract] [Full Text] [Related]

  • 24. Chapter 16. Enzymology of beta-lactam compounds with cephem structure produced by actinomycete.
    Liras P, Demain AL.
    Methods Enzymol; 2009 Aug; 458():401-29. PubMed ID: 19374992
    [Abstract] [Full Text] [Related]

  • 25. Interaction of beta-lactamases I and II from Bacillus cereus with semisynthetic cephamycins. Kinetic studies.
    Martin Villacorta J, Arriaga P, Laynez J, Menendez M.
    Biochem J; 1991 Oct 01; 279 ( Pt 1)(Pt 1):111-4. PubMed ID: 1930129
    [Abstract] [Full Text] [Related]

  • 26. Antihypertensive effects of a highly potent and long-acting angiotensin II subtype-1 receptor antagonist, (+-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H- benzimidazole-7-carboxylate (TCV-116), in various hypertensive rats.
    Inada Y, Wada T, Shibouta Y, Ojima M, Sanada T, Ohtsuki K, Itoh K, Kubo K, Kohara Y, Naka T.
    J Pharmacol Exp Ther; 1994 Mar 01; 268(3):1540-7. PubMed ID: 8138966
    [Abstract] [Full Text] [Related]

  • 27. Metabolic disposition of 6-ethyl-3-(1H-tetrazol-5-yl)-chromone, a new antiallergic agent, in the rat, guinea-pig, rabbit, dog and monkey.
    Kanai Y, Nakai Y, Nakajima N, Tanayama S.
    Xenobiotica; 1979 Jan 01; 9(1):33-50. PubMed ID: 104449
    [Abstract] [Full Text] [Related]

  • 28. [Review [new antibiotics series IV]: latamoxef (author's transl)].
    Matsumoto K.
    Jpn J Antibiot; 1982 Mar 01; 35(3):704-13. PubMed ID: 6212703
    [No Abstract] [Full Text] [Related]

  • 29. [Absorption, excretion and distribution of 14C-labelled 6-[D(-)-alpha-(4-ethyl-2, 3-dioxo-1-piperazinecarboxamido)-alpha-phenylacetamido] penicillanic acid (14C-T-1220) in rats and mice (author's transl)].
    Saikawa I, Takai A, Nakajima Y, Yasuda T, Shimizu E.
    Jpn J Antibiot; 1977 Aug 01; 30(8):571-81. PubMed ID: 909145
    [No Abstract] [Full Text] [Related]

  • 30. [Studies on beta-lactam antibiotics for medicinal purpose. V. Structure of degradation products of 6-[D(--)-alpha-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)phenylacetamido]penicillanic acid (T-1220) in aqueous solution (author's transl)].
    Takano S, Yoshida C, Sakai H, Yamamoto Y, Tai M.
    Yakugaku Zasshi; 1977 Oct 01; 97(10):1064-70. PubMed ID: 592098
    [No Abstract] [Full Text] [Related]

  • 31. Synthesis and antinociceptive activity of some substituted-{5-[2-(1,2,3,4-tetrahydrocarbazol-9-yl)ethyl]tetrazol-1-yl}alkanones.
    Rajasekaran A, Thampi PP.
    Eur J Med Chem; 2005 Dec 01; 40(12):1359-64. PubMed ID: 16169128
    [Abstract] [Full Text] [Related]

  • 32. General pharmacology of beraprost sodium. 2nd communication: effect on the autonomic, cardiovascular and gastrointestinal systems, and other effects.
    Murata T, Murai T, Kanai T, Ogaki Y, Sanai K, Kanda H, Sato S, Kajikawa N, Umetsu T, Matsuura H.
    Arzneimittelforschung; 1989 Aug 01; 39(8):867-76. PubMed ID: 2510743
    [Abstract] [Full Text] [Related]

  • 33. A novel class of local antiinflammatory steroids. 2nd communication: pharmacological studies of methyl 11 beta,17 alpha,21- trihydroxy-3,20-dioxo-pregna-1,4-diene-16 alpha-carboxylate and methyl 11 beta,21-dihydroxy-3,20-dioxo-pregna-1,4-diene-16 alpha-carboxylate.
    Heiman AS, Kim HP, Taraporewala IB, Lee HJ.
    Arzneimittelforschung; 1989 Feb 01; 39(2):262-7. PubMed ID: 2567170
    [Abstract] [Full Text] [Related]

  • 34. [Studies on the shift of cefmetazole into the gastrointestinal tract (author's transl)].
    Minamitani M, Hayashi H, Tohma T, Kojima T, Sahashi Y, Terao T.
    Jpn J Antibiot; 1980 Jan 01; 33(1):10-7. PubMed ID: 6929355
    [Abstract] [Full Text] [Related]

  • 35. Synthesis of some novel triazole derivatives as anti-nociceptive and anti-inflammatory agents.
    Rajasekaran A, Rajagopal KA.
    Acta Pharm; 2009 Sep 01; 59(3):355-64. PubMed ID: 19819831
    [Abstract] [Full Text] [Related]

  • 36. Intraoperative serum, bile, and gallbladder-wall concentrations of cefmetazole in patients undergoing cholecystectomy.
    Ito MK, Gill MA, Chenella FC, Berne TV, Yellin AE, Heseltine PN, Appleman MD.
    Clin Pharm; 1988 Jun 01; 7(6):467-8. PubMed ID: 3165314
    [No Abstract] [Full Text] [Related]

  • 37. APD791, 3-methoxy-n-(3-(1-methyl-1h-pyrazol-5-yl)-4-(2-morpholinoethoxy)phenyl)benzamide, a novel 5-hydroxytryptamine 2A receptor antagonist: pharmacological profile, pharmacokinetics, platelet activity and vascular biology.
    Adams JW, Ramirez J, Shi Y, Thomsen W, Frazer J, Morgan M, Edwards JE, Chen W, Teegarden BR, Xiong Y, Al-Shamma H, Behan DP, Connolly DT.
    J Pharmacol Exp Ther; 2009 Oct 01; 331(1):96-103. PubMed ID: 19628629
    [Abstract] [Full Text] [Related]

  • 38. New comparative method of the pharmacokinetics of the 2 antibiotics by HPLC analysis after simultaneous administration.
    Huang WF.
    Nihon Geka Hokan; 1983 May 01; 52(3):273-98. PubMed ID: 6639261
    [No Abstract] [Full Text] [Related]

  • 39. [Recent development of beta-lactam drugs (author's transl)].
    Kuwahara S.
    Nihon Saikingaku Zasshi; 1979 Sep 01; 34(5):713-30. PubMed ID: 392125
    [No Abstract] [Full Text] [Related]

  • 40. Pharmacological properties of GABAA receptors containing gamma1 subunits.
    Khom S, Baburin I, Timin EN, Hohaus A, Sieghart W, Hering S.
    Mol Pharmacol; 2006 Feb 01; 69(2):640-9. PubMed ID: 16272224
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.